Edition:
United Kingdom

Nicox SA (NCOX.PA)

NCOX.PA on Paris Stock Exchange

5.37EUR
9:37am BST
Change (% chg)

€-0.06 (-1.10%)
Prev Close
€5.43
Open
€5.40
Day's High
€5.45
Day's Low
€5.37
Volume
33,338
Avg. Vol
109,029
52-wk High
€9.38
52-wk Low
€4.36

Select another date:

Mon, Dec 17 2018

Nicox teams up with Chinese firm to develop and sell glaucoma drug

PARIS French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive licence agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.

Nicox teams up with Chinese firm to develop and sell glaucoma drug

PARIS French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.

Nicox teams up with Chinese firm to develop and sell glaucoma drug

PARIS, Dec 17 French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive licence agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.

Healthcare group Nicox postpones NASDAQ listing due to market volatility

PARIS, Oct 30 French healthcare and ophthalmology company Nicox said it had decided to postpone plans to list shares on the U.S. NASDAQ stock market, in the latest example of a company dropping stock market flotation plans due to market volatility.

Select another date: